For patients and healthcare providers researching EGFR lung cancer medicines in the Philippines, Osimertinib is one targeted treatment option used for eligible patients with specific EGFR-mutated non-small cell lung cancer.
LetsMeds provides pharmaceutical sourcing support for oncology medicines, including Osimertinib 80 mg, serving healthcare providers and customers throughout the Philippines.
Our service covers major locations including Metro Manila, Quezon City, Makati, Cebu City, Davao City, Taguig, Pasig, and other areas.
To ask about Osimertinib availability and price Contact LetsMeds: